To define multiple sclerosis (MS) disease activity and neurologic outcomes after exposure to immune checkpoint inhibitors (ICIs) as cancer therapy.
No takes yet. Share an insight, caveat, or question.
Quinn et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: